๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

โœ Scribed by Hung Huynh; Pierce K.H. Chow; Nallasivam Palanisamy; Manuel Salto-Tellez; Boon Cher Goh; Chi Kuen Lee; Anaji Somani; How Sung Lee; Ramnarayanan Kalpana; Kun Yu; Puay Hoon Tan; Jeanie Wu; Richie Soong; Ming Hui Lee; Henley Hor; Khee Chee Soo; Han Chong Toh; Patrick Tan


Book ID
116651580
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
863 KB
Volume
49
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Sorafenib suppresses postsurgical recurr
โœ Yu-Xiong Feng; Tao Wang; Yue-Zhen Deng; Pengyuan Yang; Jing-Jing Li; Dong-Xian G ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 846 KB

Surgical resection is the first-line treatment for hepatocellular carcinoma (HCC) patients with well-preserved liver function. Nevertheless, the rate of postoperative recurrence at 5 years is as high as 70%, and this gravely jeopardizes the therapeutic outcome. Clearly, new approaches are needed for